Lorlatinib
About
Therapy type: Targeted therapy
Therapy strategy: ALK inhibition
Mappings
NCI Thesaurus: Lorlatinib (coding:ncit:C113655)
RxNorm: lorlatinib (coding:rxcui:2103164, coding:omop:35201733)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (2) FDA (2) | v::ALK | Non-Small Cell Lung Cancer | Lorlatinib |